HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
(3-Bromo-2-methylphenyl)methanol
3-BroMo-2-Methylbenzyl alcohol · 2-methyl-3-bromobenzyl alcohol · (3-broMo-2-Methylphenyl)Methano · (3-broMo-2-Methylphenyl)Methanol · 3-Bromo-2-methylbenzylalcohol97% · 3-Bromo-2-methyl-benzenemethanol · 3-Bromo-2-methylbenzyl alcohol 97% · Benzenemethanol, 3-bromo-2-methyl-

Identifikatoren & physikalische Daten
| CAS No. | 83647-43-2 |
|---|---|
| Summenformel | C8H9BrO |
| Durchschnittliche Molmasse | 201,06 g/mol |
| Monoisotopische Masse | 199,98367701 g/mol |
| SMILES | Cc1c(Br)cccc1CO |
| InChIKey | XYDXDWXAAQXHLK-UHFFFAOYSA-N |
| PubChem CID | 10035697 |
| EC No. | 112-305-7 |
| DTXSID | DTXSID30434495 |
Chemische & physikalische Eigenschaften
| XLogP | 2,1 |
|---|---|
| Polarare Oberfläche (TPSA) | 20,2 |
| H-Brücken-Donoren | 1 |
| H-Brücken-Akzeptoren | 1 |
| Frei drehbare Bindungen | 1 |
| Schwere Atome | 10 |
| Formalladung | 0 |
| Komplexität | 105 |
| Schmelzpunkt | 103-104 °C(Solv: benzene (71-43-2)) |
| Siedepunkt | 286.4±25.0 °C(Predicted) |
| Dichte | 1.481±0.06 g/cm3(Predicted) |
| Lagerbedingungen | Sealed in dry,Room Temperature |
| Aggregatzustand | crystalline needles |
| pKa (Säurekonstante) | 14.29±0.10(Predicted) |
| Farbe | Faint beige to faint brown |
Sicherheit & Vorschriften
| GHS-Einstufung | WarningH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|---|
| Hazard Classes and Categories | Acute Tox. 4 (100%) |
| Zollcode | 2906290090 |
Anwendungen & Verwendung
Beschreibung
3-Bromo-2-methylbenzyl alcohol is a pharmaceutical intermediate, which is obtained by esterification and reduction of 3-bromo-2-methylbenzoic acid. Literature reports that 3-bromo-2-methylbenzyl alcohol can be used to prepare fused ring compounds as PD-1/PD-L1 inhibitors, which have the advantages of high activity, high bioavailability, drug stability, and oral administration.